Mehta SH - Search Results

1

Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.

Lucas GM, Atta MG, Zook K, McFall AM, Mehta SH, Fine DM, Stein JH, Schwartz GJ. Lucas GM, et al. Among authors: mehta sh. AIDS. 2016 Feb 20;30(4):619-26. doi: 10.1097/QAD.0000000000000949. AIDS. 2016. PMID: 26558732 Free PMC article.

2

Protection against persistence of hepatitis C.

Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL. Mehta SH, et al. Lancet. 2002 Apr 27;359(9316):1478-83. doi: 10.1016/S0140-6736(02)08435-0. Lancet. 2002. PMID: 11988247

3

Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.

Sulkowski MS, Mehta SH, Chaisson RE, Thomas DL, Moore RD. Sulkowski MS, et al. Among authors: mehta sh. AIDS. 2004 Nov 19;18(17):2277-84. doi: 10.1097/00002030-200411190-00008. AIDS. 2004. PMID: 15577540

4

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.

Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Sulkowski MS, et al. Among authors: mehta sh. AIDS. 2005 Mar 24;19(6):585-92. doi: 10.1097/01.aids.0000163935.99401.25. AIDS. 2005. PMID: 15802977

5

The effect of HIV infection on overdose mortality.

Wang C, Vlahov D, Galai N, Cole SR, Bareta J, Pollini R, Mehta SH, Nelson KE, Galea S. Wang C, et al. Among authors: mehta sh. AIDS. 2005 Jun 10;19(9):935-42. doi: 10.1097/01.aids.0000171407.30866.22. AIDS. 2005. PMID: 15905674

6

A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users.

Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. Mehta SH, et al. AIDS. 2005 Oct;19 Suppl 3:S179-89. doi: 10.1097/01.aids.0000192088.72055.90. AIDS. 2005. PMID: 16251816 Review.

7

Serum albumin as a prognostic indicator for HIV disease progression.

Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Mehta SH, et al. AIDS Res Hum Retroviruses. 2006 Jan;22(1):14-21. doi: 10.1089/aid.2006.22.14. AIDS Res Hum Retroviruses. 2006. PMID: 16438640

8

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.

Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Mehta SH, et al. AIDS. 2006 Nov 28;20(18):2361-9. doi: 10.1097/QAD.0b013e32801086da. AIDS. 2006. PMID: 17117023

9

End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004.

Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. Lucas GM, et al. Among authors: mehta sh. AIDS. 2007 Nov 30;21(18):2435-43. doi: 10.1097/QAD.0b013e32827038ad. AIDS. 2007. PMID: 18025880

10

Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.

Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL. Sulkowski MS, et al. Among authors: mehta sh. AIDS. 2007 Oct 18;21(16):2209-16. doi: 10.1097/QAD.0b013e3282f10de9. AIDS. 2007. PMID: 18090048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters